Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers

INTRODUCTION: Major cardiovascular risk factors, including hypertension and dyslipidemia, are often comorbidities, frequently leading to concurrent prescription of angiotensin receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins). The study’s objective was to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yewon, Lee, SeungHwan, Jang, In-Jin, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063220/
https://www.ncbi.nlm.nih.gov/pubmed/30087555
http://dx.doi.org/10.2147/DDDT.S165171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063220/
https://www.ncbi.nlm.nih.gov/pubmed/30087555
http://dx.doi.org/10.2147/DDDT.S165171

Ejemplares similares